Authorities step up investigation into vaping-related lung disease


  • Mary Corcoran
  • Univadis Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

The US Centers for Disease Control and Prevention (CDC) has activated its Emergency Operations Center (EOC) to enhance the response to the current investigation into cases of lung injury linked to e-cigarette product use. 

The EOC brings together teams of highly trained experts and state-of-the-art technology to help strengthen the response to public health threats. Since its inception in 2001, it has responded to threats such as hurricanes, food-borne disease outbreaks, Ebola and Zika virus.

The CDC says its activation of the EOC will allow the agency to provide increased operational support for the response to meet the outbreak’s evolving challenges. 

It comes as the latest data show 380 confirmed and probable cases of lung disease associated with e-cigarette product use or vaping have been reported in the US. Earlier this week, authorities confirmed a man in California had become the seventh person to die as a result of the vaping-related illness. 

While all of those affected have reported e-cigarette product use, no consistent e-cigarette or vaping product, substance or additive has been identified in all cases, nor has any one product or substance been conclusively linked to lung disease in patients, according to the CDC.